EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gingerenone A Attenuates Ulcerative Colitis via Targeting IL‐17RA to Inhibit Inflammation and Restore Intestinal Barrier Function

Jian Liang, Weigang Dai, Chuanghui Liu, Yifan Wen, Chen Chen, Yifei Xu, Song Huang, Shaozhen Hou, Chun Li, Yongming Chen, Wei Wang, Hailin Tang iD

Advanced Science · 2024-07 · 11 (28)

DOI: 10.1002/advs.202400206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.04.2024. Verfasst von Jian Liang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Disease Models, Animal, Intestinal Mucosa, Receptors, Interleukin-17. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province China, Foundation and Applied Basic Research Fund Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a complicated and recurrent intestinal disease. Currently available drugs for UC treatment are scarce, therefore, novel therapeutic drugs for the UC are urgently to be developed. Gingerenone A (GA) is a phenolic compound known for its anti‐inflammatory effect, but its effect on UC remains unknown. Here, it is shown that GA protects mice against UC, which is closely associated with inhibiting intestinal mucosal inflammation and enhancing intestinal barrier integrity in vivo and in vitro. Of note, RNA sequencing analysis demonstrates an evident correlation with IL‐17 signaling pathway after GA treatment, and this effect is further corroborated by Western blot. Mechanistically, GA directly interacts with IL‐17RA protein through pull‐down, surface plasmon resonance analysis and molecular dynamics simulation. Importantly, lentivirus‐mediated IL‐17RA/Act1 knock‐down or GA co‐treatment with brodalumab/ixekizumab significantly impairs the protective effects of GA against DSS‐induced inflammation and barrier dysfunction, suggesting a critical role of IL‐17RA signaling for GA‐mediated protection against UC. Overall, these results indicate that GA is an effective agent against UC mainly through the direct binding of IL‐17RA to inhibit inflammatory signaling activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeDisease Models, AnimalIntestinal MucosaReceptors, Interleukin-17AnimalsMaleMiceAnti-Inflammatory AgentsInflammationIntestinal Barrier FunctionMice, Inbred C57BLSignal Transduction

Stichwörter der Autor:innen

gingerenone Ail‐17RA signalinginflammationintestinal barrierulcerative colitis

Substanzen

Anti-Inflammatory AgentsIl17ra protein, mouseReceptors, Interleukin-17

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan, 523808, China.
  • Center of Ganstric Cancer, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510062, China.
  • Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518033, China.

ORCID-Profile: Hailin Tang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province China
  • Foundation and Applied Basic Research Fund Project of Guangdong Province
  • Guangzhou Science and Technology Bureau
  • Science and Technology Program of Guangzhou
  • The core technology project in the field of biological industry
  • Regional Union Fund-Regional Nurturing Project
  • Science and technology project in key fields of Nansha District

Zitieren

APA

Liang, J., Dai, W., Liu, C., Wen, Y., Chen, C., Xu, Y., Huang, S., Hou, S., Li, C., Chen, Y., Wang, W., & Tang, H. (2024). Gingerenone A Attenuates Ulcerative Colitis via Targeting IL‐17RA to Inhibit Inflammation and Restore Intestinal Barrier Function. Advanced Science, 11(28). https://doi.org/10.1002/advs.202400206

Vancouver

Liang J, Dai W, Liu C, Wen Y, Chen C, Xu Y, et al. Gingerenone A Attenuates Ulcerative Colitis via Targeting IL‐17RA to Inhibit Inflammation and Restore Intestinal Barrier Function. Advanced Science. 2024;11(28). doi:10.1002/advs.202400206

BibTeX
@article{Liang2024,
  author = {Liang, Jian and Dai, Weigang and Liu, Chuanghui and Wen, Yifan and Chen, Chen and Xu, Yifei and Huang, Song and Hou, Shaozhen and Li, Chun and Chen, Yongming and Wang, Wei and Tang, Hailin},
  title = {Gingerenone A Attenuates Ulcerative Colitis via Targeting IL‐17RA to Inhibit Inflammation and Restore Intestinal Barrier Function},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {28},
  doi = {10.1002/advs.202400206}
}
Kostenlos starten →